VANCOUVER, July 9, 2018 /PRNewswire/ – INVICTUS MD STRATEGIES CORP. (“Invictus” or the “Company”) (TSXV: GENE; OTC: IVITF; FRA: 8IS1) announced today the purchase of an additional acre of neighboring land adjacent to AB Laboratories Inc. (“AB Labs”) property, dedicated to future expansion opportunities at the facility. The acquisition represents significant progress in AB Labs’ growth strategy which involves building a strong production profile in state-of-the-art cultivation spaces. Construction of the Phase 2 expansion at AB Labs remains on-schedule. Phase 2Read more
- Vertically integrated cannabis firm Ascend Wellness raises $55 million for expansion
- Lifeline Biotechnologies Updates Shareholders and The Public
- Financial Gravity Selects Securities Transfer Corporation as Transfer Agent
- Wayfair Reports 58% Increase in Direct Retail Sales for Peak Five-Day Holiday Shopping Weekend
- Marijuana tech firm Metrc gets $50M with help from Snoop Dogg, Tiger Global
SMALL CAP MARKET NEWS
We release small market news updates daily, 5 times a week! Always check back to get the inside scoop on what going on.
LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!
Stock Investors · Accredited Investors · Hedge Fund InvestorsLearn More